Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/04/2003WO2003099849A2 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use
12/04/2003WO2003099681A1 Container for the generation of therapeutic microfoam
12/04/2003WO2003099362A1 Aerosol drug inhibition of lung metastases
12/04/2003WO2003099334A1 Topically applicable pharmaceutical preparation
12/04/2003WO2003099314A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003WO2003099311A1 Chewable compositions containing a gel-forming extract of psyllium
12/04/2003WO2003099309A1 Active fraction having anti-cancer and anti-metastasis isolated from acanthopanax species and fruits
12/04/2003WO2003099308A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
12/04/2003WO2003099301A1 Formulation containing tetrodotoxin for abstinence and analgecize which is administered through respiratory tract
12/04/2003WO2003099297A1 Treatment of mucositis
12/04/2003WO2003099295A1 Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions
12/04/2003WO2003099291A1 Progestagenic dosage units
12/04/2003WO2003099290A1 Pharmaceutical products and methods of manufacture
12/04/2003WO2003099288A1 Medicinal composition
12/04/2003WO2003099281A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes
12/04/2003WO2003099280A1 Novel formulation for the parenteral application of crobenetine
12/04/2003WO2003099278A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
12/04/2003WO2003099267A1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
12/04/2003WO2003099264A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003WO2003099263A1 At least partially degradable films containing an active ingredient and method for the production thereof
12/04/2003WO2003099262A1 Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
12/04/2003WO2003099261A1 Liposome drug delivery
12/04/2003WO2003099260A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2003WO2003099259A1 Oleaginous oral antiparasitic compositions
12/04/2003WO2003099258A1 Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
12/04/2003WO2003099256A2 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES)
12/04/2003WO2003099214A2 Biguanide formulations
12/04/2003WO2003099213A2 Method for reducing platelet count
12/04/2003WO2003099203A2 Enteric coated caffeine tablet
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099200A2 Composition and method for the treatment of diaper rash using natural products
12/04/2003WO2003099197A2 Formulations of erythromycin derivatives with improved bioavailability
12/04/2003WO2003099163A1 Vehicles for delivery of biologically active substances
12/04/2003WO2003099112A1 Microparticles having a matrix interior useful for ultrasound triggered delivery of drugs into the bloodstream
12/04/2003WO2003099007A1 Aqueous fludarabine phosphate composition
12/04/2003WO2003090818A3 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003WO2003088948A3 Microemulsions for selective molecular separation
12/04/2003WO2003080629A3 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
12/04/2003WO2003075977A3 Agglomerated particles for aerosol drug delivery
12/04/2003WO2003075928A3 Stable pharmaceutical compositions
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003070194A3 Amino acid and peptide-modified forms of glucocorticoids
12/04/2003WO2003069998A8 Stable compositions comprising tezacitabine
12/04/2003WO2003065928A3 Therapeutic polyesters and polyamides
12/04/2003WO2003063823A3 Osmotic delivery system
12/04/2003WO2003063785A3 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
12/04/2003WO2003061600A3 Device for transcutaneous drug delivery and uses therefor
12/04/2003WO2003061593A3 Novel targeted compositions for diagnostic and therapeutic use
12/04/2003WO2003061578A3 Compositions for treatment or prevention of bioterrorism
12/04/2003WO2003059807A3 Crystalline solids of carvedilol and processes for their preparation
12/04/2003WO2003059332A3 Use of an anti-microtubule agent for the treatment of uveitis
12/04/2003WO2003059263A3 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions.
12/04/2003WO2003057852A3 Purification and characterization of hla proteins
12/04/2003WO2003057170A3 Oral insulin therapy
12/04/2003WO2003053465A3 Lyophilized preparation containing antibodies to the egf receptor
12/04/2003WO2003053357A3 Method and related composition employing nanostructures
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003049786A3 Metering valve and pharmaceutical metered dose inhaler and methods thereof
12/04/2003WO2003039523A3 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
12/04/2003WO2003030878A3 Galenic microparticulate oral formulation
12/04/2003WO2003030867A3 Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid
12/04/2003WO2003029417A3 Nutrient medium for maintaining neural cells in injured nervous system
12/04/2003WO2003028736A3 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised
12/04/2003WO2003024406A3 Nestin-expressing hair follicle stem cells
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003WO2003017941A3 Flexible applicator for applying oil-in-water emulsion with improved stability
12/04/2003WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2002098515A3 Topical treatments using alkanolamines
12/04/2003WO2002083626A3 Alkyl and/or alkenyl glycerol carbamates
12/04/2003WO2002074193A3 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
12/04/2003WO2002069897A3 Method and apparatus for compounding individualized dosage forms
12/04/2003WO2002043774A3 Compositions and therapeutical use of polynucleotides encoding tcrs
12/04/2003US20030225450 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003US20030225396 Rapid infusion system
12/04/2003US20030225394 Comprises sodium chloride, sesame oils, essential oils, peppermint oils, and eucalyptus oil in syringe
12/04/2003US20030225354 Bandages having pockets between multilayer, removable coverings for containing particle such as dextran or anibiotics; wound healing agents
12/04/2003US20030225300 Compounds and compositions for delivering active agents
12/04/2003US20030225163 Sulfonamide derivatives
12/04/2003US20030225160 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225144 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders
12/04/2003US20030225137 2-pyridinyl)-methyl)sulfinyl)-1H-benzimidazole derivatives
12/04/2003US20030225136 Heterocyclic imines such as (5)6-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H -benzimidazole and salts, used as antisecretory agents
12/04/2003US20030225135 Dry-blend pharmaceutical formulations
12/04/2003US20030225124 Mixing an ACE inhibitor with an alcohol to form an alcoholic dispersion; mixing a metal compound into said dispersion; and mixing said dispersion and said metal compound; stabilized ACE inhibitor is quinapril sodium or enalapril sodium
12/04/2003US20030225114 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4- oxopyrimidines
12/04/2003US20030225104 Pharmaceutical compositions for poorly soluble drugs
12/04/2003US20030225089 Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225050 Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
12/04/2003US20030225048 Sulfatase inhibiting continuous progestogen contraceptive regimens
12/04/2003US20030225047 Sulfatase inhibiting progestogen-only contraceptive regimens
12/04/2003US20030225041 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation.
12/04/2003US20030225039 Method of treatment using bisphosphonic acid
12/04/2003US20030225033 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof
12/04/2003US20030225032 Pharmaceutical composition
12/04/2003US20030225031 Liquid or gel solution for nasal administration also containing a permeation-enhancement agent for transmucosal drug uptake.
12/04/2003US20030225020 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
1 ... 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 ... 2991